Business Description
Iverheal 6 Mg operates by targeting parasitic organisms at their core. Its mode of action involves disrupting neurotransmission, crucial for the survival of these organisms. By interfering with their neurotransmitters, particularly gamma-amino butyric acid (GABA), it induces paralysis and eventual death of the parasites. Additionally, Ivermectin impacts parasitic metabolism, further weakening their ability to thrive within the host's body. Metabolized primarily in the liver, it undergoes biotransformation before being excreted, predominantly through faces. Factors such as age, weight, and liver function can influence its pharmacokinetics, necessitating careful consideration in dosage determination.
